On the National Stock Exchange (NSE), Aurobindo Pharma Ltd fell 0.9% daily. The stock slipped to 35.44% in 2021 compared to a 5.59% rally in Nifty and a 5.09% fall in the Nifty Metal index.
Aurobindo Pharma Ltd went down for a fifth straight session on December 9 2022. The stock is quoting at Rs 454.7, down 0.9% on the NSE. The benchmark Nifty is down around 0.64%, quoting 18490.6.
- Mumbai Office Leasing and Residential Sales Grow in 2024
- Nvidia Launches New RTX 50 Series GPU
- Consint.AI Secures Rs 5 Crore Funding in Seed Round
- Arkade Developers Adds 3 New Redevelopment Projects
- India Launches a New Steel PLI Scheme
The Sensex is at 62,131.96, down 0.7%. Aurobindo Pharma Ltd eased around 4.83% in 2021. Meanwhile, the Nifty Metal index of which Aurobindo Pharma Ltd has reduced by about 1.71% in 2021 and recently up 0.26% on the day. The volume in the stock stood at 5.64 lakh shares on December 9, 2022, compared to the daily average of 25.9 lakh shares in September.
In the December futures contract, the benchmark for the stock is quoted at Rs 456.7, down 1.02%. Aurobindo Pharma Ltd slipped to 35.44% in 2021 compared to a 5.59% rally in Nifty and a 5.09% fall in the Nifty Metal index.
As of September’s end, the stock’s PE is 19.19 based on TTM earnings.
